Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Q2 2018 Sentiment Report

October 2, 2018 - By Marie Mckinney

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Logo

Sentiment for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) institutional sentiment decreased to 0.87 in 2018 Q2. Its down -0.20, from 1.07 in 2018Q1. The ratio has dropped, as 95 investment managers increased and started new positions, while 109 sold and reduced equity positions in Allscripts Healthcare Solutions Inc. The investment managers in our partner’s database now have: 172.07 million shares, down from 182.67 million shares in 2018Q1. Also, the number of investment managers holding Allscripts Healthcare Solutions Inc in their top 10 positions decreased from 3 to 2 for a decrease of 1. Sold All: 29 Reduced: 80 Increased: 66 New Position: 29.

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. The company has market cap of $2.40 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. It has a 1246.82 P/E ratio. The companyÂ’s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

The stock increased 1.14% or $0.155 during the last trading session, reaching $13.715. About 283,673 shares traded. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has risen 6.92% since October 2, 2017 and is uptrending. It has underperformed by 8.70% the S&P500.

Analysts await Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to report earnings on November, 1. They expect $0.14 EPS, up 16.67 % or $0.02 from last year’s $0.12 per share. MDRX’s profit will be $24.45M for 24.49 P/E if the $0.14 EPS becomes a reality. After $0.13 actual EPS reported by Allscripts Healthcare Solutions, Inc. for the previous quarter, Wall Street now forecasts 7.69 % EPS growth.

Adirondack Research & Management Inc. holds 2.44% of its portfolio in Allscripts Healthcare Solutions, Inc. for 521,177 shares. Paradigm Capital Management Inc Ny owns 2.06 million shares or 2% of their US portfolio. Moreover, Dalton Greiner Hartman Maher & Co has 1.95% invested in the company for 3.17 million shares. The Pennsylvania-based S&T Bank Pa has invested 1.37% in the stock. Community Trust & Investment Co, a Kentucky-based fund reported 830,332 shares.

Since January 1, 0001, it had 1 buy, and 4 sales for $632,856 activity.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Ratings Coverage

Ratings analysis reveals 100% of Allscripts’s analysts are positive. Out of 6 Wall Street analysts rating Allscripts, 6 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $15.5 while the high is $1800. The stock’s average target of $16.25 is 18.48% above today’s ($13.715) share price. MDRX was included in 7 notes of analysts from April 5, 2018. The rating was upgraded by SunTrust on Friday, May 4 to “Buy”. The company was initiated on Tuesday, April 24 by J.P. Morgan. Bank of America maintained the shares of MDRX in report on Friday, May 4 with “Buy” rating. The rating was maintained by Cowen & Co with “Buy” on Wednesday, April 18. The rating was maintained by Cantor Fitzgerald on Thursday, June 7 with “Buy”. On Thursday, April 5 the stock rating was maintained by Cantor Fitzgerald with “Buy”. Canaccord Genuity maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Friday, August 3 with “Buy” rating.

More notable recent Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) news were published by: Globenewswire.com which released: “Allscripts appointed to Health Systems Support Framework” on September 11, 2018, also Nasdaq.com with their article: “EPSi announces partnership with Ilerasoft” published on September 17, 2018, Globenewswire.com published: “Allscripts to present at the 2018 Cantor Fitzgerald Global Healthcare Conference” on October 01, 2018. More interesting news about Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) were released by: Globenewswire.com and their article: “EPSi announces partnership with MPA Healthcare Solutions” published on September 13, 2018 as well as Nasdaq.com‘s news article titled: “Wyckoff Heights Medical Center selects Sunriseâ„¢ Abstracting to collect core measure data and monitor key …” with publication date: September 11, 2018.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>